Croatia infection control market is estimated to increase with a growth rate of 6.04% by the end of 2025.The presence of numerous healthcare institutions resulting in the treatment of more than 760.000 patients every year is driving the market demand in the forecast period. The increasing mortality mainly due to the high prevalence of cardiovascular diseases is further augmenting the market demand in the forecast period owing to the utilization of infection control products in diagnosis and treatment procedures. The average length of stay for acute hospital care is more than 8 days in 2015, which is slightly higher than the EU average. Hence, this is projected to drive the market demand in the forecast period. The substantial cases of road accidents due to the presence of deadlier roads and inefficient judiciary is contributing to the surge in the length of hospital stays for acute patient care.
The greater length of hospital stay in Croatia is estimated to drive the market demand in the forecast period.
According to the Eurostat estimates, the length of hospital stay in Croatia was recorded 9.3 among other countries in the European Union, in 2016. The number was the second highest after the Czech Republic. Hence, in order to avoid hospital-associated infections, the demand for infection control products will continue to surge in the forecast period. Despite low levels of health expenditure of the country, there are sufficient resources in the health system in order to deal with severe health issues including accidents, further providing an opportunity for the market to thrive in the forecast period. However, number of health workers is accounted to be low in number, this factor will not affect the market growth over the next five years. The major reasons for a long stay in hospitals are attributed to the higher bed occupancy rates of acute care patients and a high prevalence of patients suffering from cardiovascular diseases requiring long-term care.
The growing trend of minimally invasive surgeries in the world, Croatia is also following the trend where companies based in this country are offering products, further surging the market demand in the forecast period and in the upcoming years.
With the growing adoption of minimally invasive surgery at the global level, companies situated in Croatia are also offering minimally invasive devices to be utilized by surgeons to perform various surgeries. With advancements made in the field of minimally invasive cardiac surgery, Karl Storz Croatia is offering products for the treatment of cardiac diseases. This includes equipment related to mitral valve surgery and endoscopic atrial ablation among other products. The higher number of patients suffering from cardiovascular diseases in Croatia will provide an opportunity for the market to thrive with the adoption of minimally invasive procedures for disease treatment. One of the recent pieces of evidence of minimally invasive surgery conducted in the Zagreb Clinical Hospital Centre, the physicians performed a unique procedure for repairing a giant aneurysm of the pelvic artery. This complex and risky surgery was performed in two hours through a small incision. The surgery with a complicated aortic anatomic condition was recorded to be performed first time in the medical history. The announcement was made at a press conference on 10th September 2019.